|
1
|
Coskun HH, Ferlito A, Medina JE, Robbins
KT, Rodrigo JP, Strojan P, Suárez C, Takes RP, Woolgar JA, Shaha
AR, et al: Retropharyngeal lymph node metastases in head and neck
malignancies. Head Neck. 33:1520–1529. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kimura Y, Hanazawa T, Sano T and Okano T:
Lateral retropharyngeal node metastasis from carcinoma of the upper
gingiva and maxillary sinus. AJNR Am J Neuroradiol. 19:1221–1224.
1998.PubMed/NCBI
|
|
3
|
Nishida M, Yasuda S, Murakami K, Yamamura
I, Nagata Y and Iizuka T: Retropharyngeal lymph node metastases
from oral cancer: A report of 2 patients. J Oral Maxillofac Surg.
63:410–412. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Umeda M, Shigeta T, Takahashi H, Kataoka
T, Oguni A, Minamikawa T, Shibuya Y, Yokoo S and Komori T:
Metastasis to the lateral retropharyngeal lymph node from squamous
cell carcinoma of the oral cavity: Report of three cases. Int J
Oral Maxillofac Surg. 38:1004–1008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tseng JR, Ho TY, Lin CY, Lee LY, Wang HM,
Liao CT and Yen TC: Clinical outcomes of patients with oral cavity
squamous cell carcinoma and retropharyngeal lymph node metastasis
identified by FDG PET/CT. PLoS One. 8:e797662013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vermorken JB, Remenar E, van Herpen C,
Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss
JH, et al: Cisplatin, fluorouracil and docetaxel in unresectable
head and neck cancer. N Engl J Med. 357:1695–1704. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Posner MR, Hershock DM, Blajman CR,
Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM,
Cullen K, Ervin TJ, et al: Cisplatin and fluorouracil alone or with
docetaxel in head and neck cancer. N Engl J Med. 357:1705–1715.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Watarai J, Seino Y, Kobayashi M, Shindo M
and Kato T: CT of retropharyngeal lymph node metastasis from
maxillary carcinoma. Acta Radiol. 34:492–495. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tauzin M, Rabalais A, Hagan JL, Wood CG,
Ferris RL and Walvekar RR: PET-CT staging of the neck in cancers of
the oropharynx: Patterns of regional and retropharyngeal nodal
metastasis. World J Surg Oncol. 8:702010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amatsu M, Mohri M and Kinishi M:
Significance of retropharyngeal node dissection at radical surgery
for carcinoma of the hypopharynx and cervical esophagus.
Laryngoscope. 111:1099–1103. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kamiyama R, Saikawa M and Kishimoto S:
Significance of retropharyngeal lymph node dissection in
hypopharyngeal cancer. Jpn J Clin Oncol. 39:632–637. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Umeda M, Minamikawa T, Komatsubara H,
Ojima Y, Shibuya Y, Yokoo S and Komori T: En bloc resection of the
primary tumour and cervical lymph nodes through the parapharyngeal
space in patients with squamous cell carcinoma of the maxilla: A
preliminary study. Br J Oral Maxillofac Surg. 43:17–22. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pfister DG, Spencer S, Brizel DM, Burtness
B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele
DW, et al: Head and neck cancers, Version 2.2014. Clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 12:1454–1487. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marta GN, Riera R, Bossi P, Zhong LP,
Licitra L, Macedo CR, de Castro Junior G, Carvalho AL, William WN
Jr and Kowalski LP: Induction chemotherapy prior to surgery with or
without postoperative radiotherapy for oral cavity cancer patients:
Systematic review and meta-analysis. Eur J Cancer. 51:2596–2603.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lau A, Li KY, Yang WF and Su YX: Induction
chemotherapy for squamous cell carcinomas of the oral cavity: A
cumulative meta-analysis. Oral Oncol. 61:104–114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grégoire V, Lefebvre JL, Licitra L and
Felip E: EHNS-ESMO-ESTRO Guidelines Working Group: Squamous cell
carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 21
Suppl 5:v184–v186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Teo M, Karakaya E, Young CA, Dyker KE,
Coyle C, Sen M and Prestwich RJ: The efficacy of induction
chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined
with cisplatin concurrent chemoradiotherapy for locally advanced
head and neck squamous cell carcinoma: A matched pair analysis.
Clin Oncol (R Coll Radiol). 25:647–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang L, Jiang N, Shi Y, Li S, Wang P and
Zhao Y: Induction chemotherapy with concurrent chemoradiotherapy
versus concurrent chemoradiotherapy for locally advanced squamous
cell carcinoma of head and neck: A meta-analysis. Sci Rep.
5:107982015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hitt R, Grau JJ, López-Pousa A, Berrocal
A, García-Girón C, Irigoyen A, Sastre J, Martínez-Trufero J,
Brandariz Castelo JA, Verger E, et al: A randomized phase III trial
comparing induction chemotherapy followed by chemoradiotherapy
versus chemoradiotherapy alone as treatment of unresectable head
and neck cancer. Ann Oncol. 25:216–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Budach W, Bölke E, Kammers K, Gerber PA,
Orth K, Gripp S and Matuschek C: Induction chemotherapy followed by
concurrent radio-chemotherapy versus concurrent radio-chemotherapy
alone as treatment of locally advanced squamous cell carcinoma of
the head and neck (HNSCC): A meta-analysis of randomized trials.
Radiother Oncol. 118:238–243. 2016. View Article : Google Scholar : PubMed/NCBI
|
